{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:59:15Z","timestamp":1788339555404,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100022831","name":"Sa\u011fl\u0131k Bilimleri \u00dcniversitesi","doi-asserted-by":"publisher","award":["2022\/230"],"award-info":[{"award-number":["2022\/230"]}],"id":[{"id":"10.13039\/100022831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11126-024-10102-w","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:37:16Z","timestamp":1731044236000},"page":"19-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Are S100B and VILIP-1 Involved in a Common Mechanism of Neuroinflammation in Major Depressive Disorder?"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0865-2818","authenticated-orcid":false,"given":"Nagihan","family":"Ayaz Nayc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0683-5207","authenticated-orcid":false,"given":"Aybeniz","family":"Civan Kahve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-6013","authenticated-orcid":false,"given":"Hasan","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2950-2680","authenticated-orcid":false,"given":"Anda\u00e7","family":"Uzdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5759-8694","authenticated-orcid":false,"given":"Ya\u011fmur","family":"Darben Azars\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-8177","authenticated-orcid":false,"given":"S\u00fcreyya","family":"Barun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-2817","authenticated-orcid":false,"given":"Erol","family":"G\u00f6ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"10102_CR1","unstructured":"Association AP. (2000) Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Chronic Diseaes 157:1\u201345."},{"key":"10102_CR2","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299\u2013312. https:\/\/doi.org\/10.1016\/S0140-6736(18)31948-2.","journal-title":"Lancet"},{"key":"10102_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11427-020-1815-6","volume":"64","author":"X Jia","year":"2021","unstructured":"Jia X, Gao Z, Hu H. Microglia in depression: current perspectives. Sci China Life Sci. 2021;64:911\u201325. https:\/\/doi.org\/10.1007\/s11427-020-1815-6.","journal-title":"Sci China Life Sci"},{"key":"10102_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"S Ronald","year":"2016","unstructured":"Ronald S, Duman PD, George K, Aghajanian MD, Sanacora G, M.D., Ph.D., and, John H, Krystal MD. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238\u201349. https:\/\/doi.org\/10.1038\/nm.4050.","journal-title":"Nat Med"},{"key":"10102_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/1381612053382223","volume":"11","author":"J Malberg","year":"2005","unstructured":"Malberg J, Schechter L. Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Curr Pharm Des. 2005;11:145\u201355. https:\/\/doi.org\/10.2174\/1381612053382223.","journal-title":"Curr Pharm Des"},{"key":"10102_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","volume":"29","author":"OJG Schiepers","year":"2005","unstructured":"Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Prog Neuro-Psychopharmacology Biol Psychiatry. 2005;29:201\u201317. https:\/\/doi.org\/10.1016\/j.pnpbp.2004.11.003.","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"key":"10102_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Maes M, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135:373\u201387. https:\/\/doi.org\/10.1111\/acps.12698.","journal-title":"Acta Psychiatr Scand"},{"key":"10102_CR8","doi-asserted-by":"publisher","first-page":"105957","DOI":"10.1016\/j.phrs.2021.105957","volume":"174","author":"Q Liu","year":"2021","unstructured":"Liu Q, Li R, Yang W, et al. Role of neuroglia in neuropathic pain and depression. Pharmacol Res. 2021;174:105957. https:\/\/doi.org\/10.1016\/j.phrs.2021.105957.","journal-title":"Pharmacol Res"},{"key":"10102_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuroscience.2018.03.034","volume":"403","author":"M Woelfer","year":"2019","unstructured":"Woelfer M, Kasties V, Kahlfuss S, Walter M. The role of depressive subtypes within the Neuroinflammation hypothesis of major depressive disorder. Neuroscience. 2019;403:93\u2013110. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.03.034.","journal-title":"Neuroscience"},{"key":"10102_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/npp.2016.199","volume":"42","author":"E Haroon","year":"2017","unstructured":"Haroon E, Miller AH, Sanacora G. Inflammation, glutamate, and Glia: a Trio of trouble in Mood disorders. Neuropsychopharmacology. 2017;42:193\u2013215. https:\/\/doi.org\/10.1038\/npp.2016.199.","journal-title":"Neuropsychopharmacology"},{"key":"10102_CR11","doi-asserted-by":"publisher","unstructured":"Villanueva R. Neurobiology of major depressive disorder. Neural Plast. 2013;1\u20137. https:\/\/doi.org\/10.1155\/2013\/873278.","DOI":"10.1155\/2013\/873278"},{"key":"10102_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/138161210790883741","volume":"16","author":"C Lanni","year":"2010","unstructured":"Lanni C, Stanga S, Racchi M, Govoni S. The Expanding Universe of neurotrophic factors: therapeutic potential in Aging and Age-Associated disorders. Curr Pharm Des. 2010;16:698\u2013717. https:\/\/doi.org\/10.2174\/138161210790883741.","journal-title":"Curr Pharm Des"},{"key":"10102_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jpsychires.2021.04.019","volume":"138","author":"E Koz\u0142owska","year":"2021","unstructured":"Koz\u0142owska E, Brzezi\u0144ska-B\u0142aszczyk E, Agier J, et al. Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia. J Psychiatr Res. 2021;138:380\u20137. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.04.019.","journal-title":"J Psychiatr Res"},{"key":"10102_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2174\/13894501113149990014","volume":"14","author":"ML Schroeter","year":"2013","unstructured":"Schroeter ML, Mueller K, Sacher J, et al. Serum S100B represents a New Biomarker for Mood disorders. Curr Drug Targets. 2013;14:1237\u201348. https:\/\/doi.org\/10.2174\/13894501113149990014.","journal-title":"Curr Drug Targets"},{"key":"10102_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0924-977X(03)00016-6","volume":"13","author":"V Arolt","year":"2003","unstructured":"Arolt V, Peters M, Erfurth A, et al. S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacol. 2003;13:235\u20139. https:\/\/doi.org\/10.1016\/S0924-977X(03)00016-6.","journal-title":"Eur Neuropsychopharmacol"},{"key":"10102_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00213-004-1999-z","volume":"178","author":"G Hetzel","year":"2005","unstructured":"Hetzel G, Moeller O, Evers S, et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology. 2005;178:161\u20136. https:\/\/doi.org\/10.1007\/s00213-004-1999-z.","journal-title":"Psychopharmacology"},{"key":"10102_CR17","doi-asserted-by":"publisher","unstructured":"Mcgrowder DA, Miller F, Vaz K, et al. Brain sciences cerebrospinal fluid biomarkers of Alzheimer \u2019 s Disease: current evidence and future perspectives. Brain Sci. 2021;1\u201356. https:\/\/doi.org\/10.3390\/brainsci11020215.","DOI":"10.3390\/brainsci11020215"},{"key":"10102_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S1570-9639(02)00452-1","volume":"1600","author":"C Spilker","year":"2002","unstructured":"Spilker C, Gundelfinger ED, Braunewell K-H. Evidence for different functional properties of the neuronal calcium sensor proteins VILIP-1 and VILIP-3: from subcellular localization to cellular function. Biochim Biophys Acta - Proteins Proteom. 2002;1600:118\u201327. https:\/\/doi.org\/10.1016\/S1570-9639(02)00452-1.","journal-title":"Biochim Biophys Acta - Proteins Proteom"},{"key":"10102_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JAD-150060","volume":"47","author":"M Groblewska","year":"2015","unstructured":"Groblewska M, Muszy\u0144ski P, Wojtulewska-Supron A, et al. The role of Visinin-Like Protein-1 in the pathophysiology of Alzheimer\u2019s Disease. J Alzheimer\u2019s Dis. 2015;47:17\u201332. https:\/\/doi.org\/10.3233\/JAD-150060.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10102_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-4-20","volume":"4","author":"P Marambaud","year":"2009","unstructured":"Marambaud P, Dreses-Werringloer U, Vingtdeux V. Calcium signaling in neurodegeneration. Mol Neurodegener. 2009;4:1\u201315. https:\/\/doi.org\/10.1186\/1750-1326-4-20.","journal-title":"Mol Neurodegener"},{"key":"10102_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.nbd.2008.07.008","volume":"32","author":"P Gierke","year":"2008","unstructured":"Gierke P, Zhao C, Bernstein H-G, et al. Implication of neuronal Ca2+-sensor protein VILIP-1 in the glutamate hypothesis of schizophrenia. Neurobiol Dis. 2008;32:162\u201375. https:\/\/doi.org\/10.1016\/j.nbd.2008.07.008.","journal-title":"Neurobiol Dis"},{"key":"10102_CR22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/sj.mp.4000811","volume":"5","author":"HK Manji","year":"2000","unstructured":"Manji HK, Moore GJ, Rajkowska G, Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry. 2000;5:578\u201393. https:\/\/doi.org\/10.1038\/sj.mp.4000811.","journal-title":"Mol Psychiatry"},{"key":"10102_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4306\/pi.2008.5.3.193","volume":"5","author":"BS Jang","year":"2008","unstructured":"Jang BS, Kim H, Lim SW, et al. Serum S100B levels and major depressive disorder: its characteristics and role in antidepressant response. Psychiatry Investig. 2008;5:193\u20138. https:\/\/doi.org\/10.4306\/pi.2008.5.3.193.","journal-title":"Psychiatry Investig"},{"key":"10102_CR24","doi-asserted-by":"publisher","unstructured":"First MB. (2015) Structured Clinical Interview for the DSM (SCID). Encycl Clin Psychol 1\u20136. https:\/\/doi.org\/10.1002\/9781118625392.wbecp351","DOI":"10.1002\/9781118625392.wbecp351"},{"key":"10102_CR25","first-page":"51","volume":"30","author":"M Elbir","year":"2019","unstructured":"Elbir M, Topba\u015f \u00d6A, Bayad S, et al. Adaptation and reliability of the structured clinical interview for DSM-5-Disorders - Clinician Version (SCID-5\/CV) to the Turkish Language. T\u00fcrk Psikiyatr Derg. 2019;30:51\u20136.","journal-title":"T\u00fcrk Psikiyatr Derg"},{"key":"10102_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. Scale for depression. J Neurol Neurosurg Psychiat. 1960;23:56\u201363. https:\/\/doi.org\/10.1136\/jnnp.23.1.56.","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10102_CR27","doi-asserted-by":"publisher","unstructured":"Akdemir A, T\u00fcrk\u00e7apar MH, \u00d6rsel SD, et al. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry. 2001;42:161\u20135. https:\/\/doi.org\/10.1053\/comp.2001.19756","DOI":"10.1053\/comp.2001.19756"},{"key":"10102_CR28","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. Global impressions scale: applying a research. Psychiatry (Edgmont). 2007;4:28\u201337.","journal-title":"Psychiatry (Edgmont)"},{"key":"10102_CR29","doi-asserted-by":"publisher","unstructured":"Schroeter ML, Abdul-Khaliq H, Sacher J, et al. Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol. 2010;1\u20137. https:\/\/doi.org\/10.1155\/2010\/780645.","DOI":"10.1155\/2010\/780645"},{"key":"10102_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000054922","volume":"44","author":"HJ Grabe","year":"2001","unstructured":"Grabe HJ, Ahrens N, Rose HJ, et al. Neurotrophic factor S100beta in major depression. Neuropsychobiology. 2001;44:88\u201390. https:\/\/doi.org\/10.1159\/000054922.","journal-title":"Neuropsychobiology"},{"key":"10102_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0165-0327(00)00321-9","volume":"66","author":"M Rothermundt","year":"2001","unstructured":"Rothermundt M, Arolt V, Wiesmann M, et al. S-100B is increased in melancholic but not in non-melancholic major depression. J Affect Disord. 2001;66:89\u201393. https:\/\/doi.org\/10.1016\/S0165-0327(00)00321-9.","journal-title":"J Affect Disord"},{"key":"10102_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/15622975.2021.2013042","volume":"23","author":"U Tural","year":"2022","unstructured":"Tural U, Irvin MK, Iosifescu DV. Correlation between S100B and severity of depression in MDD: a meta-analysis. World J Biol Psychiatry. 2022;23:456\u201363.","journal-title":"World J Biol Psychiatry"},{"key":"10102_CR33","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/00001756-200209160-00021","volume":"13","author":"ML Schroeter","year":"2002","unstructured":"Schroeter ML, Abdul-Khaliq H, Diefenbacher A, Blasig IE. S100B is increased in mood disorders and may be reduced by antidepressive treatment. NeuroReport. 2002;13:1675\u20138. https:\/\/doi.org\/10.1097\/00001756-200209160-00021.","journal-title":"NeuroReport"},{"key":"10102_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyv103","volume":"19","author":"O Ambr\u00e9e","year":"2015","unstructured":"Ambr\u00e9e O, Bergink V, Grosse L, et al. S100B serum levels predict treatment response in patients with melancholic depression. Int J Neuropsychopharmacol. 2015;19:1\u20139. https:\/\/doi.org\/10.1093\/ijnp\/pyv103.","journal-title":"Int J Neuropsychopharmacol"},{"key":"10102_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0012691","volume":"5","author":"N Pham","year":"2010","unstructured":"Pham N, Fazio V, Cucullo L, et al. Extracranial sources of S100B do not affect serum levels. PLoS ONE. 2010;5:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0012691.","journal-title":"PLoS ONE"},{"key":"10102_CR36","doi-asserted-by":"publisher","unstructured":"Tikhonova MA, Shvaikovskaya AA, Zhanaeva SY, et al. Concordance between the in vivo content of Neurospecific Proteins (BDNF, NSE, VILIP-1, S100B) in the Hippocampus and blood in patients with Epilepsy. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25010502.","DOI":"10.3390\/ijms25010502"},{"key":"10102_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000019252","volume":"99","author":"D Liu","year":"2020","unstructured":"Liu D, Dong X, Yang R, et al. Visinin-like protein-1 level is associated with short-term functional outcome of acute ischemic stroke: a prospective cohort study. Med (United States). 2020;99:1\u20134. https:\/\/doi.org\/10.1097\/MD.0000000000019252.","journal-title":"Med (United States)"},{"key":"10102_CR38","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.ajem.2019.02.037","volume":"37","author":"A Algin","year":"2019","unstructured":"Algin A, Erdogan MO, Aydin I, et al. Clinical usefulness of brain-derived neurotrophic factor and visinin-like protein-1 in early diagnostic tests for acute stroke. Am J Emerg Med. 2019;37:2051\u20134. https:\/\/doi.org\/10.1016\/j.ajem.2019.02.037.","journal-title":"Am J Emerg Med"},{"key":"10102_CR39","doi-asserted-by":"publisher","unstructured":"Bernstein H-G, Braunewell K-H, Spilker C, et al. Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia. NeuroReport. 2002;13. https:\/\/doi.org\/10.1097\/00001756-200203250-00006.","DOI":"10.1097\/00001756-200203250-00006"},{"key":"10102_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.567587","volume":"11","author":"Z Tan","year":"2020","unstructured":"Tan Z, Jiang J, Tian F, et al. Serum Visinin-Like protein 1 is a better Biomarker Than Neuron-Specific Enolase for Seizure-Induced neuronal Injury: a prospective and observational study. Front Neurol. 2020;11:1\u20137. https:\/\/doi.org\/10.3389\/fneur.2020.567587.","journal-title":"Front Neurol"},{"key":"10102_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","volume":"129","author":"S Amor","year":"2010","unstructured":"Amor S, Puentes F, Baker D, Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129:154\u201369. https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03225.x.","journal-title":"Immunology"},{"key":"10102_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/s0896-6273(02)00794-8","volume":"35","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Mucke L. Review inflammation in neurodegenerative Disease\u2014A double-edged Sword emanating from injured neurons, or by imbalances be- tween pro-and antiinflammatory processes. Inflammatory responses also recruit immune mecha. Neuron. 2002;35:419\u201332. https:\/\/doi.org\/10.1016\/s0896-6273(02)00794-8.","journal-title":"Neuron"},{"key":"10102_CR43","doi-asserted-by":"publisher","unstructured":"Sai K, Nakanishi A, Scofield KM, et al. Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer\u2019s disease mouse models. J Cell Sci. 2023;136. https:\/\/doi.org\/10.1242\/jcs.260102.","DOI":"10.1242\/jcs.260102"},{"key":"10102_CR44","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41380-019-0615-x","volume":"25","author":"RB Price","year":"2020","unstructured":"Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry. 2020;25:530\u201343. https:\/\/doi.org\/10.1038\/s41380-019-0615-x.","journal-title":"Mol Psychiatry"},{"key":"10102_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R Troubat","year":"2021","unstructured":"Troubat R, Barone P, Leman S, et al. Neuroinflammation and depression: a review. Eur J Neurosci. 2021;53:151\u201371. https:\/\/doi.org\/10.1111\/ejn.14720.","journal-title":"Eur J Neurosci"},{"key":"10102_CR46","doi-asserted-by":"publisher","unstructured":"Schenatto CB, Xavier RM, Bredemeier M, et al. Raised serum S100B protein levels in neuropsychiatric lupus. Ann Rheum Dis. 2006;65. https:\/\/doi.org\/10.1136\/ard.2005.048330.:829 LP\u2013 831.","DOI":"10.1136\/ard.2005.048330"},{"key":"10102_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.nbd.2008.07.008","volume":"32","author":"P Gierke","year":"2008","unstructured":"Gierke P, Zhao C, Bernstein H, et al. Neurobiology of Disease Implication of neuronal ca 2 + -sensor protein VILIP-1 in the glutamate hypothesis of schizophrenia. Neurobiol Dis. 2008;32:162\u201375. https:\/\/doi.org\/10.1016\/j.nbd.2008.07.008.","journal-title":"Neurobiol Dis"},{"key":"10102_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00429-011-0346-5","volume":"217","author":"S K\u00fchn","year":"2012","unstructured":"K\u00fchn S, Romanowski A, Schilling C, et al. Brain grey matter deficits in smokers: focus on the cerebellum. Brain Struct Funct. 2012;217:517\u201322. https:\/\/doi.org\/10.1007\/s00429-011-0346-5.","journal-title":"Brain Struct Funct"},{"key":"10102_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0006-3223(03)00610-3","volume":"55","author":"AL Brody","year":"2004","unstructured":"Brody AL, Mandelkern MA, Jarvik ME, et al. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry. 2004;55:77\u201384. https:\/\/doi.org\/10.1016\/S0006-3223(03)00610-3.","journal-title":"Biol Psychiatry"},{"key":"10102_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neubiorev.2018.11.017","volume":"96","author":"AA Conti","year":"2019","unstructured":"Conti AA, McLean L, Tolomeo S, et al. Chronic tobacco smoking and neuropsychological impairments: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;96:143\u201354. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.11.017.","journal-title":"Neurosci Biobehav Rev"},{"key":"10102_CR51","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.3390\/ijerph7103760","volume":"7","author":"TC Durazzo","year":"2010","unstructured":"Durazzo TC, Meyerhoff DJ, Nixon SJ. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health. 2010;7:3760\u201390. https:\/\/doi.org\/10.3390\/ijerph7103760.","journal-title":"Int J Environ Res Public Health"},{"key":"10102_CR52","doi-asserted-by":"publisher","first-page":"41872","DOI":"10.1074\/jbc.M206857200","volume":"277","author":"EM Lin, Jeanclos","year":"2002","unstructured":"Lin, Jeanclos EM, Treuil M, et al. The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the \u03b14\u03b22 nicotinic acetylcholine receptor. J Biol Chem. 2002;277:41872\u20138. https:\/\/doi.org\/10.1074\/jbc.M206857200.","journal-title":"J Biol Chem"},{"key":"10102_CR53","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.tips.2005.04.008","volume":"26","author":"KH Braunewell","year":"2005","unstructured":"Braunewell KH. The darker side of Ca2\u2009+\u2009signaling by neuronal ca 2+-sensor proteins: from Alzheimer\u2019s disease to cancer. Trends Pharmacol Sci. 2005;26:345\u201351. https:\/\/doi.org\/10.1016\/j.tips.2005.04.008.","journal-title":"Trends Pharmacol Sci"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-024-10102-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11126-024-10102-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-024-10102-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T05:58:17Z","timestamp":1742709497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11126-024-10102-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10102"],"URL":"https:\/\/doi.org\/10.1007\/s11126-024-10102-w","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"3 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants in the study were informed about the study, and their verbal consent was obtained along with written consent using an informed consent form. All volunteers who agreed to participate in the study were informed that they had the right to refuse participation or terminate the interview at any time, and they were assured that their records would be kept confidential. Informed consent was obtained from all individual participants included in the study. Patients signed informed consent regarding publishing their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate and Publication"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}